News

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...
MIT researchers have developed a new theoretical framework for studying the mechanisms of treatment interactions. Their ...
Pittsburgh Penguins general manager Kyle Dubas wants no talk of tanking and quickly pushed back on any insinuations to the ...
While the U.S. stock market has rebounded, the combination of the Trump tariffs, a volatile dollar and an erratic bond market ...
Corina Dutcus, SVP, oncology global clinical development lead at Eisai, discusses the potential of the E7386 and lenvatinib ...
Forecast: Pick the two horses to finish first and second in a race. With a straight forecast, the bettor must predict the ...
Learn how striking the right balance with plant growth regulators can reduce fruit drop in 'Honeycrisp' without sacrificing ...
Pharmacy researchers at the National University of Singapore (NUS) have demonstrated that multi-component interventions are ...
Round Robin bets work in conjunction with parlay bets. Round Robins provide combinations of the initial parlay you build. For ...
Having a team of internal and external stakeholders — such as school IT and facilities directors, law enforcement and other ...
Following the FDA ODAC's vote against belantamab mafodotin-based combinations in relapsed/refractory multiple myeloma, George Mulligan, PhD, provides insight into the agent's potential path foward.